Ardent Health Q1 2026: Revenue $1.60B (+7%), Adjusted EBITDA $124M (+26%), Reaffirms FY Guidance

Ardent Health, Inc.

2026-Q1 EPS reported $0.28 revenue$1,601,870,000

Total revenue $1.602B (+7.0% YoY); net income $40M ($0.28 diluted EPS) vs $41M ($0.29) a year ago.
Adjusted EBITDA $124M (+26.3% YoY); excluding $10.9M gain, growth was 15%.
Adjusted admissions +2.0%, total surgeries +1.2%; admissions -1.1% due to severe weather and light respiratory season.
Reaffirmed FY2026 guidance: revenue $6.4–$6.7B, Adj EBITDA $485–$535M, diluted EPS $0.90–$1.27.
Lease-adjusted net leverage improved to 2.6x from 3.0x a year ago; cash $610M, total debt $1.1B.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.